Should close contacts of a person with TB be screened? 

Identifying and screening individuals who have been in close proximity to an active case of tuberculosis (TB) is a fundamental pillar of public health management in the United Kingdom. When a person is diagnosed with active tuberculosis, particularly when the infection is located in the lungs or throat, they can inadvertently pass the bacteria to those with whom they spend significant amounts of time. Screening is not only about finding others who might be currently ill, it is primarily a preventive strategy designed to identify “latent” infections. By testing close contacts, the NHS can provide early intervention and treatment, effectively stopping the bacteria from progressing to active disease or spreading further through the community. 

What We’ll Discuss in This Article 

• The clinical definition of a close contact in tuberculosis exposure. 

• Why screening is mandatory for those exposed to pulmonary or laryngeal TB. 

• The specific tests used to screen asymptomatic contacts. 

• The “window period” and why timing is crucial for accurate results. 

• What happens if a contact test returns a positive result. 

• The role of local TB nursing teams in the contact tracing process. 

Defining a close contact in tuberculosis exposure 

In the context of tuberculosis, a close contact is not simply someone you have passed in the street or spoken to briefly. The risk of transmission depends on the duration of exposure and the proximity to the infectious person. Close contacts are typically defined as people who share a household or communal living space with someone diagnosed with active TB. This includes family members, flatmates, and partners. Outside the home, close contact may also include work colleagues or students who share an office or classroom for extended periods. Generally, the local TB team considers anyone who has had cumulative exposure of eight hours or more as a priority for screening, although this threshold may be lower for vulnerable individuals such as children or those with weakened immune systems. 

The importance of screening for close contacts 

Screening is necessary because tuberculosis bacteria can enter the body and remain dormant for years without causing any outward symptoms. This state, known as latent tuberculosis, is not contagious, but it carries a lifelong risk of “reactivating” into active, infectious disease. Everyone who has been in close contact with someone diagnosed with active TB may need testing to check whether they are infected. By identifying these latent infections early, healthcare providers can offer preventative antibiotics that kill the dormant bacteria. This proactive approach significantly reduces the overall number of tuberculosis cases in the UK and protects the health of the individual contact, who might otherwise become severely ill months or years later. 

The clinical testing process for contacts 

The screening process for contacts is designed to be thorough but is tailored to the person’s age and health status. If a contact has symptoms such as a persistent cough or weight loss, they are usually sent immediately for a chest X-ray and sputum tests. However, for those who feel fine, the process often begins with an immune system test. The Mantoux test is the standard method used in the UK to screen for tuberculosis in children and some adults. Alternatively, an Interferon-Gamma Release Assay (IGRA) blood test may be used, especially for adults who have previously received the BCG vaccine. Because it can take up to 12 weeks for the immune system to react to the bacteria, a “repeat” test may be required if the first test was performed too soon after the last contact with the infectious person. 

Understanding latent and active TB results 

When a contact is screened, there are three possible outcomes: no infection, latent infection, or active disease. If the tests are negative after the appropriate window period, the person is considered uninfected. A positive skin or blood test, combined with a clear chest X-ray, indicates a latent infection. This means the person has the bacteria in their body but is not sick and cannot spread it. Only TB of the lungs or throat is infectious to other people, so someone with latent TB or TB in other parts of the body (extra-pulmonary) does not pose a risk to their friends or family. If a latent infection is found, the individual is usually offered a course of preventative antibiotics to eliminate the risk of future illness. 

The role of the TB contact tracing team 

Contact tracing is a specialized service provided by local NHS TB clinics and public health teams. When a patient is diagnosed with active TB, a specialist nurse will conduct a “contact interview” to identify everyone who might have been exposed. The team then reaches out to these individuals to explain the risk and arrange screening. This service is entirely confidential and free of charge for everyone in the UK, regardless of their residency status. The contact tracing team provides not only testing but also education and support, helping to reduce the stigma often associated with the disease. Their work is vital for ensuring that every person at risk is found and offered the appropriate medical care. 

Conclusion 

Screening close contacts is an essential part of managing tuberculosis in the United Kingdom. It identifies individuals with latent infections who may not even know they have been exposed, allowing for preventative treatment that stops the disease in its tracks. While the process may seem daunting, it is a routine public health measure designed to protect both the individual and the wider community. By participating in screening and following the advice of the local TB team, contacts can ensure their long term health and contribute to the eventual elimination of tuberculosis. 

If you experience severe, sudden, or worsening symptoms, such as a severe headache with a stiff neck, sudden confusion, or coughing up blood, call 999 immediately. 

Authority Snapshot (E-E-A-T Block) 

This article provides clinical guidance on the tuberculosis contact tracing and screening protocols used within the United Kingdom. All information is strictly aligned with the evidence based standards and pathways established by the NHS and the National Institute for Health and Care Excellence (NICE). The content has been authored by a dedicated medical writing team and reviewed by Dr. Stefan Petrov, a UK-trained physician, to ensure accuracy and patient safety.